Synageva Biopharma Corp.
Q4 2014 13F Holders
Symbol
GEVA
CUSIP
87159A103
Type
Equity
Class
COM
Num filings
134
Total reported value, excl. options
$3.39 B
Compare 2014 Q4 to
2015 Q1
2014 Q3
2014 Q2
2014 Q1
Manager
Report Date
Value ($000)
Shares
Option Type